nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisdexamfetamine—Cardiomyopathy—Imiquimod—skin cancer	0.0251	0.0253	CcSEcCtD
Lisdexamfetamine—Abdominal pain upper—Vismodegib—skin cancer	0.0161	0.0163	CcSEcCtD
Lisdexamfetamine—Cardiomyopathy—Fluorouracil—skin cancer	0.0138	0.0139	CcSEcCtD
Lisdexamfetamine—Sudden death—Fluorouracil—skin cancer	0.0138	0.0139	CcSEcCtD
Lisdexamfetamine—Weight decreased—Vismodegib—skin cancer	0.0138	0.0139	CcSEcCtD
Lisdexamfetamine—Digestion impaired—Temozolomide—skin cancer	0.0115	0.0116	CcSEcCtD
Lisdexamfetamine—Malnutrition—Vismodegib—skin cancer	0.0106	0.0107	CcSEcCtD
Lisdexamfetamine—Aggression—Bleomycin—skin cancer	0.0104	0.0104	CcSEcCtD
Lisdexamfetamine—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.00983	0.00991	CcSEcCtD
Lisdexamfetamine—Cerebrovascular accident—Imiquimod—skin cancer	0.0095	0.00957	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00899	0.00907	CcSEcCtD
Lisdexamfetamine—Irritability—Imiquimod—skin cancer	0.00888	0.00895	CcSEcCtD
Lisdexamfetamine—Weight decreased—Vemurafenib—skin cancer	0.00853	0.0086	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Vismodegib—skin cancer	0.00851	0.00858	CcSEcCtD
Lisdexamfetamine—Skin disorder—Vismodegib—skin cancer	0.00843	0.0085	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00834	0.0084	CcSEcCtD
Lisdexamfetamine—Lacosamide—SCN10A—skin cancer	0.00807	1	CrCbGaD
Lisdexamfetamine—Dyspepsia—Vismodegib—skin cancer	0.00764	0.0077	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Vismodegib—skin cancer	0.00755	0.00761	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Vismodegib—skin cancer	0.00749	0.00756	CcSEcCtD
Lisdexamfetamine—Fatigue—Vismodegib—skin cancer	0.00748	0.00755	CcSEcCtD
Lisdexamfetamine—Constipation—Vismodegib—skin cancer	0.00742	0.00748	CcSEcCtD
Lisdexamfetamine—Erectile dysfunction—Imiquimod—skin cancer	0.00741	0.00747	CcSEcCtD
Lisdexamfetamine—Depression—Imiquimod—skin cancer	0.00715	0.00721	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Vemurafenib—skin cancer	0.00714	0.0072	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00711	0.00717	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Imiquimod—skin cancer	0.00707	0.00713	CcSEcCtD
Lisdexamfetamine—Eye disorder—Vemurafenib—skin cancer	0.00705	0.00711	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Imiquimod—skin cancer	0.00703	0.00709	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Vemurafenib—skin cancer	0.00701	0.00706	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Vemurafenib—skin cancer	0.0068	0.00686	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Imiquimod—skin cancer	0.00678	0.00684	CcSEcCtD
Lisdexamfetamine—Cerebrovascular accident—Bleomycin—skin cancer	0.00675	0.0068	CcSEcCtD
Lisdexamfetamine—Malnutrition—Vemurafenib—skin cancer	0.00657	0.00662	CcSEcCtD
Lisdexamfetamine—Asthenia—Vismodegib—skin cancer	0.00623	0.00628	CcSEcCtD
Lisdexamfetamine—Visual impairment—Imiquimod—skin cancer	0.0062	0.00625	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Imiquimod—skin cancer	0.00609	0.00614	CcSEcCtD
Lisdexamfetamine—Euphoric mood—Fluorouracil—skin cancer	0.00608	0.00613	CcSEcCtD
Lisdexamfetamine—Eye disorder—Imiquimod—skin cancer	0.00602	0.00607	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Vismodegib—skin cancer	0.00594	0.00599	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Imiquimod—skin cancer	0.00581	0.00586	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Imiquimod—skin cancer	0.0058	0.00585	CcSEcCtD
Lisdexamfetamine—Mental disorder—Imiquimod—skin cancer	0.00564	0.00569	CcSEcCtD
Lisdexamfetamine—Malnutrition—Imiquimod—skin cancer	0.0056	0.00565	CcSEcCtD
Lisdexamfetamine—Diplopia—Temozolomide—skin cancer	0.00558	0.00562	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00556	0.0056	CcSEcCtD
Lisdexamfetamine—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.00555	0.0056	CcSEcCtD
Lisdexamfetamine—Vomiting—Vismodegib—skin cancer	0.00552	0.00556	CcSEcCtD
Lisdexamfetamine—Affect lability—Temozolomide—skin cancer	0.00549	0.00553	CcSEcCtD
Lisdexamfetamine—Rash—Vismodegib—skin cancer	0.00547	0.00552	CcSEcCtD
Lisdexamfetamine—Dermatitis—Vismodegib—skin cancer	0.00547	0.00551	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Vemurafenib—skin cancer	0.00536	0.00541	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Vemurafenib—skin cancer	0.00526	0.0053	CcSEcCtD
Lisdexamfetamine—Skin disorder—Vemurafenib—skin cancer	0.00521	0.00525	CcSEcCtD
Lisdexamfetamine—Weight decreased—Bleomycin—skin cancer	0.00517	0.00521	CcSEcCtD
Lisdexamfetamine—Nausea—Vismodegib—skin cancer	0.00516	0.0052	CcSEcCtD
Lisdexamfetamine—Agitation—Imiquimod—skin cancer	0.00515	0.00519	CcSEcCtD
Lisdexamfetamine—Angioedema—Imiquimod—skin cancer	0.00512	0.00516	CcSEcCtD
Lisdexamfetamine—Blood pressure increased—Docetaxel—skin cancer	0.00511	0.00515	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Bleomycin—skin cancer	0.00502	0.00506	CcSEcCtD
Lisdexamfetamine—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00502	0.00506	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Bleomycin—skin cancer	0.00499	0.00503	CcSEcCtD
Lisdexamfetamine—Palpitations—Imiquimod—skin cancer	0.00495	0.00499	CcSEcCtD
Lisdexamfetamine—Irritability—Fluorouracil—skin cancer	0.0049	0.00494	CcSEcCtD
Lisdexamfetamine—Convulsion—Imiquimod—skin cancer	0.00486	0.00489	CcSEcCtD
Lisdexamfetamine—Hypertension—Imiquimod—skin cancer	0.00484	0.00488	CcSEcCtD
Lisdexamfetamine—Anxiety—Imiquimod—skin cancer	0.00475	0.00479	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00474	0.00478	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00471	0.00475	CcSEcCtD
Lisdexamfetamine—Dry mouth—Imiquimod—skin cancer	0.00467	0.0047	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Vemurafenib—skin cancer	0.00466	0.0047	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00463	0.00467	CcSEcCtD
Lisdexamfetamine—Fatigue—Vemurafenib—skin cancer	0.00462	0.00466	CcSEcCtD
Lisdexamfetamine—Constipation—Vemurafenib—skin cancer	0.00459	0.00462	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Imiquimod—skin cancer	0.00449	0.00452	CcSEcCtD
Lisdexamfetamine—Tachycardia—Imiquimod—skin cancer	0.00446	0.0045	CcSEcCtD
Lisdexamfetamine—Skin disorder—Imiquimod—skin cancer	0.00444	0.00448	CcSEcCtD
Lisdexamfetamine—Erectile dysfunction—Temozolomide—skin cancer	0.00444	0.00448	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Imiquimod—skin cancer	0.00442	0.00446	CcSEcCtD
Lisdexamfetamine—Weight increased—Temozolomide—skin cancer	0.00439	0.00442	CcSEcCtD
Lisdexamfetamine—Weight decreased—Temozolomide—skin cancer	0.00436	0.0044	CcSEcCtD
Lisdexamfetamine—Anorexia—Imiquimod—skin cancer	0.00436	0.0044	CcSEcCtD
Lisdexamfetamine—Depression—Temozolomide—skin cancer	0.00429	0.00432	CcSEcCtD
Lisdexamfetamine—Hepatitis—Dactinomycin—skin cancer	0.00427	0.0043	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00426	0.0043	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Vemurafenib—skin cancer	0.00424	0.00427	CcSEcCtD
Lisdexamfetamine—Insomnia—Imiquimod—skin cancer	0.00414	0.00417	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Imiquimod—skin cancer	0.00408	0.00411	CcSEcCtD
Lisdexamfetamine—Somnolence—Imiquimod—skin cancer	0.00407	0.0041	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Temozolomide—skin cancer	0.00406	0.0041	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Dactinomycin—skin cancer	0.00403	0.00407	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Imiquimod—skin cancer	0.00403	0.00406	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Imiquimod—skin cancer	0.00398	0.00401	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Vemurafenib—skin cancer	0.00395	0.00398	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Imiquimod—skin cancer	0.00395	0.00398	CcSEcCtD
Lisdexamfetamine—Fatigue—Imiquimod—skin cancer	0.00394	0.00398	CcSEcCtD
Lisdexamfetamine—Visual disturbance—Docetaxel—skin cancer	0.00391	0.00395	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Fluorouracil—skin cancer	0.0039	0.00394	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Fluorouracil—skin cancer	0.00388	0.00391	CcSEcCtD
Lisdexamfetamine—Hepatitis—Temozolomide—skin cancer	0.00386	0.00389	CcSEcCtD
Lisdexamfetamine—Asthenia—Vemurafenib—skin cancer	0.00385	0.00388	CcSEcCtD
Lisdexamfetamine—Hallucination—Temozolomide—skin cancer	0.00384	0.00387	CcSEcCtD
Lisdexamfetamine—Visual impairment—Temozolomide—skin cancer	0.00372	0.00375	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Vemurafenib—skin cancer	0.00367	0.0037	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Temozolomide—skin cancer	0.00365	0.00368	CcSEcCtD
Lisdexamfetamine—Urticaria—Imiquimod—skin cancer	0.00363	0.00366	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Imiquimod—skin cancer	0.00362	0.00364	CcSEcCtD
Lisdexamfetamine—Eye disorder—Temozolomide—skin cancer	0.00361	0.00363	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Temozolomide—skin cancer	0.00358	0.00361	CcSEcCtD
Lisdexamfetamine—Dizziness—Vemurafenib—skin cancer	0.00355	0.00358	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Temozolomide—skin cancer	0.00348	0.00351	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Temozolomide—skin cancer	0.00348	0.00351	CcSEcCtD
Lisdexamfetamine—Vomiting—Vemurafenib—skin cancer	0.00341	0.00344	CcSEcCtD
Lisdexamfetamine—Abdominal pain upper—Docetaxel—skin cancer	0.00339	0.00341	CcSEcCtD
Lisdexamfetamine—Rash—Vemurafenib—skin cancer	0.00338	0.00341	CcSEcCtD
Lisdexamfetamine—Mental disorder—Temozolomide—skin cancer	0.00338	0.00341	CcSEcCtD
Lisdexamfetamine—Dermatitis—Vemurafenib—skin cancer	0.00338	0.00341	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Imiquimod—skin cancer	0.00337	0.0034	CcSEcCtD
Lisdexamfetamine—Headache—Vemurafenib—skin cancer	0.00336	0.00339	CcSEcCtD
Lisdexamfetamine—Malnutrition—Temozolomide—skin cancer	0.00336	0.00339	CcSEcCtD
Lisdexamfetamine—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00334	0.00337	CcSEcCtD
Lisdexamfetamine—Asthenia—Imiquimod—skin cancer	0.00328	0.00331	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Bleomycin—skin cancer	0.00325	0.00328	CcSEcCtD
Lisdexamfetamine—Nausea—Vemurafenib—skin cancer	0.00319	0.00321	CcSEcCtD
Lisdexamfetamine—Vision blurred—Temozolomide—skin cancer	0.00317	0.00319	CcSEcCtD
Lisdexamfetamine—Tremor—Temozolomide—skin cancer	0.00315	0.00317	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Imiquimod—skin cancer	0.00313	0.00315	CcSEcCtD
Lisdexamfetamine—Anorexia—Bleomycin—skin cancer	0.0031	0.00312	CcSEcCtD
Lisdexamfetamine—Agitation—Temozolomide—skin cancer	0.00309	0.00311	CcSEcCtD
Lisdexamfetamine—Angioedema—Temozolomide—skin cancer	0.00307	0.00309	CcSEcCtD
Lisdexamfetamine—Dizziness—Imiquimod—skin cancer	0.00302	0.00305	CcSEcCtD
Lisdexamfetamine—Palpitations—Temozolomide—skin cancer	0.00297	0.00299	CcSEcCtD
Lisdexamfetamine—Weight increased—Docetaxel—skin cancer	0.00292	0.00294	CcSEcCtD
Lisdexamfetamine—Vision blurred—Fluorouracil—skin cancer	0.00292	0.00294	CcSEcCtD
Lisdexamfetamine—Convulsion—Temozolomide—skin cancer	0.00291	0.00293	CcSEcCtD
Lisdexamfetamine—Vomiting—Imiquimod—skin cancer	0.00291	0.00293	CcSEcCtD
Lisdexamfetamine—Weight decreased—Docetaxel—skin cancer	0.0029	0.00292	CcSEcCtD
Lisdexamfetamine—Hypertension—Temozolomide—skin cancer	0.0029	0.00292	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Bleomycin—skin cancer	0.0029	0.00292	CcSEcCtD
Lisdexamfetamine—Anorexia—Dactinomycin—skin cancer	0.00289	0.00291	CcSEcCtD
Lisdexamfetamine—Rash—Imiquimod—skin cancer	0.00288	0.00291	CcSEcCtD
Lisdexamfetamine—Dermatitis—Imiquimod—skin cancer	0.00288	0.0029	CcSEcCtD
Lisdexamfetamine—Headache—Imiquimod—skin cancer	0.00287	0.00289	CcSEcCtD
Lisdexamfetamine—Anxiety—Temozolomide—skin cancer	0.00285	0.00287	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00284	0.00286	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00283	0.00286	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Bleomycin—skin cancer	0.00282	0.00285	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Docetaxel—skin cancer	0.00282	0.00284	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Docetaxel—skin cancer	0.0028	0.00282	CcSEcCtD
Lisdexamfetamine—Dry mouth—Temozolomide—skin cancer	0.0028	0.00282	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Temozolomide—skin cancer	0.00274	0.00276	CcSEcCtD
Lisdexamfetamine—Nausea—Imiquimod—skin cancer	0.00272	0.00274	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Docetaxel—skin cancer	0.0027	0.00272	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Temozolomide—skin cancer	0.00269	0.00271	CcSEcCtD
Lisdexamfetamine—Convulsion—Fluorouracil—skin cancer	0.00268	0.0027	CcSEcCtD
Lisdexamfetamine—Skin disorder—Temozolomide—skin cancer	0.00266	0.00268	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Temozolomide—skin cancer	0.00265	0.00267	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Dactinomycin—skin cancer	0.00263	0.00266	CcSEcCtD
Lisdexamfetamine—Fatigue—Dactinomycin—skin cancer	0.00261	0.00263	CcSEcCtD
Lisdexamfetamine—Anorexia—Temozolomide—skin cancer	0.00261	0.00263	CcSEcCtD
Lisdexamfetamine—Urticaria—Bleomycin—skin cancer	0.00258	0.0026	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Bleomycin—skin cancer	0.00257	0.00259	CcSEcCtD
Lisdexamfetamine—Hepatitis—Docetaxel—skin cancer	0.00257	0.00259	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Fluorouracil—skin cancer	0.00253	0.00255	CcSEcCtD
Lisdexamfetamine—Insomnia—Temozolomide—skin cancer	0.00248	0.0025	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Fluorouracil—skin cancer	0.00248	0.0025	CcSEcCtD
Lisdexamfetamine—Visual impairment—Docetaxel—skin cancer	0.00247	0.00249	CcSEcCtD
Lisdexamfetamine—Tachycardia—Fluorouracil—skin cancer	0.00246	0.00248	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Temozolomide—skin cancer	0.00244	0.00246	CcSEcCtD
Lisdexamfetamine—Somnolence—Temozolomide—skin cancer	0.00244	0.00246	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Docetaxel—skin cancer	0.00243	0.00245	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Temozolomide—skin cancer	0.00241	0.00243	CcSEcCtD
Lisdexamfetamine—Anorexia—Fluorouracil—skin cancer	0.00241	0.00243	CcSEcCtD
Lisdexamfetamine—Eye disorder—Docetaxel—skin cancer	0.0024	0.00242	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Dactinomycin—skin cancer	0.0024	0.00242	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Bleomycin—skin cancer	0.00239	0.00241	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Temozolomide—skin cancer	0.00238	0.0024	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Docetaxel—skin cancer	0.00238	0.0024	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Temozolomide—skin cancer	0.00237	0.00239	CcSEcCtD
Lisdexamfetamine—Fatigue—Temozolomide—skin cancer	0.00236	0.00238	CcSEcCtD
Lisdexamfetamine—Constipation—Temozolomide—skin cancer	0.00234	0.00236	CcSEcCtD
Lisdexamfetamine—Asthenia—Bleomycin—skin cancer	0.00233	0.00235	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Docetaxel—skin cancer	0.00232	0.00234	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Docetaxel—skin cancer	0.00231	0.00233	CcSEcCtD
Lisdexamfetamine—Insomnia—Fluorouracil—skin cancer	0.00228	0.0023	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Fluorouracil—skin cancer	0.00225	0.00227	CcSEcCtD
Lisdexamfetamine—Mental disorder—Docetaxel—skin cancer	0.00225	0.00227	CcSEcCtD
Lisdexamfetamine—Somnolence—Fluorouracil—skin cancer	0.00225	0.00226	CcSEcCtD
Lisdexamfetamine—Malnutrition—Docetaxel—skin cancer	0.00223	0.00225	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Dactinomycin—skin cancer	0.00223	0.00225	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Fluorouracil—skin cancer	0.00222	0.00224	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Fluorouracil—skin cancer	0.0022	0.00221	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00218	0.0022	CcSEcCtD
Lisdexamfetamine—Urticaria—Temozolomide—skin cancer	0.00218	0.0022	CcSEcCtD
Lisdexamfetamine—Asthenia—Dactinomycin—skin cancer	0.00217	0.00219	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Temozolomide—skin cancer	0.00217	0.00218	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Dactinomycin—skin cancer	0.00207	0.00209	CcSEcCtD
Lisdexamfetamine—Vomiting—Bleomycin—skin cancer	0.00207	0.00208	CcSEcCtD
Lisdexamfetamine—Rash—Bleomycin—skin cancer	0.00205	0.00207	CcSEcCtD
Lisdexamfetamine—Dermatitis—Bleomycin—skin cancer	0.00205	0.00206	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Temozolomide—skin cancer	0.00202	0.00204	CcSEcCtD
Lisdexamfetamine—Urticaria—Fluorouracil—skin cancer	0.00201	0.00202	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Fluorouracil—skin cancer	0.002	0.00201	CcSEcCtD
Lisdexamfetamine—Palpitations—Docetaxel—skin cancer	0.00197	0.00199	CcSEcCtD
Lisdexamfetamine—Asthenia—Temozolomide—skin cancer	0.00197	0.00198	CcSEcCtD
Lisdexamfetamine—Convulsion—Docetaxel—skin cancer	0.00194	0.00195	CcSEcCtD
Lisdexamfetamine—Nausea—Bleomycin—skin cancer	0.00193	0.00195	CcSEcCtD
Lisdexamfetamine—Hypertension—Docetaxel—skin cancer	0.00193	0.00194	CcSEcCtD
Lisdexamfetamine—Vomiting—Dactinomycin—skin cancer	0.00193	0.00194	CcSEcCtD
Lisdexamfetamine—Rash—Dactinomycin—skin cancer	0.00191	0.00193	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00189	0.0019	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Temozolomide—skin cancer	0.00188	0.00189	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Fluorouracil—skin cancer	0.00186	0.00188	CcSEcCtD
Lisdexamfetamine—Dry mouth—Docetaxel—skin cancer	0.00186	0.00187	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Docetaxel—skin cancer	0.00182	0.00184	CcSEcCtD
Lisdexamfetamine—Dizziness—Temozolomide—skin cancer	0.00181	0.00183	CcSEcCtD
Lisdexamfetamine—Nausea—Dactinomycin—skin cancer	0.0018	0.00181	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Docetaxel—skin cancer	0.00179	0.0018	CcSEcCtD
Lisdexamfetamine—Tachycardia—Docetaxel—skin cancer	0.00178	0.00179	CcSEcCtD
Lisdexamfetamine—Skin disorder—Docetaxel—skin cancer	0.00177	0.00178	CcSEcCtD
Lisdexamfetamine—Vomiting—Temozolomide—skin cancer	0.00174	0.00176	CcSEcCtD
Lisdexamfetamine—Anorexia—Docetaxel—skin cancer	0.00174	0.00175	CcSEcCtD
Lisdexamfetamine—Rash—Temozolomide—skin cancer	0.00173	0.00174	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Fluorouracil—skin cancer	0.00173	0.00174	CcSEcCtD
Lisdexamfetamine—Dermatitis—Temozolomide—skin cancer	0.00173	0.00174	CcSEcCtD
Lisdexamfetamine—Headache—Temozolomide—skin cancer	0.00172	0.00173	CcSEcCtD
Lisdexamfetamine—Dizziness—Fluorouracil—skin cancer	0.00167	0.00168	CcSEcCtD
Lisdexamfetamine—Insomnia—Docetaxel—skin cancer	0.00165	0.00166	CcSEcCtD
Lisdexamfetamine—Nausea—Temozolomide—skin cancer	0.00163	0.00164	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Docetaxel—skin cancer	0.00163	0.00164	CcSEcCtD
Lisdexamfetamine—Somnolence—Docetaxel—skin cancer	0.00162	0.00163	CcSEcCtD
Lisdexamfetamine—Vomiting—Fluorouracil—skin cancer	0.00161	0.00162	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Docetaxel—skin cancer	0.0016	0.00162	CcSEcCtD
Lisdexamfetamine—Rash—Fluorouracil—skin cancer	0.00159	0.00161	CcSEcCtD
Lisdexamfetamine—Dermatitis—Fluorouracil—skin cancer	0.00159	0.0016	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Docetaxel—skin cancer	0.00158	0.0016	CcSEcCtD
Lisdexamfetamine—Headache—Fluorouracil—skin cancer	0.00158	0.00159	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Docetaxel—skin cancer	0.00157	0.00159	CcSEcCtD
Lisdexamfetamine—Fatigue—Docetaxel—skin cancer	0.00157	0.00158	CcSEcCtD
Lisdexamfetamine—Constipation—Docetaxel—skin cancer	0.00156	0.00157	CcSEcCtD
Lisdexamfetamine—Nausea—Fluorouracil—skin cancer	0.0015	0.00151	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Docetaxel—skin cancer	0.00144	0.00145	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Docetaxel—skin cancer	0.00134	0.00135	CcSEcCtD
Lisdexamfetamine—Asthenia—Docetaxel—skin cancer	0.00131	0.00132	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Docetaxel—skin cancer	0.00125	0.00126	CcSEcCtD
Lisdexamfetamine—Dizziness—Docetaxel—skin cancer	0.00121	0.00122	CcSEcCtD
Lisdexamfetamine—Vomiting—Docetaxel—skin cancer	0.00116	0.00117	CcSEcCtD
Lisdexamfetamine—Rash—Docetaxel—skin cancer	0.00115	0.00116	CcSEcCtD
Lisdexamfetamine—Dermatitis—Docetaxel—skin cancer	0.00115	0.00116	CcSEcCtD
Lisdexamfetamine—Headache—Docetaxel—skin cancer	0.00114	0.00115	CcSEcCtD
Lisdexamfetamine—Nausea—Docetaxel—skin cancer	0.00108	0.00109	CcSEcCtD
